Castle Biosciences Inc (CSTL)
32.72
+0.55
(+1.71%)
USD |
NASDAQ |
Jan 08, 16:00
32.74
+0.02
(+0.06%)
After-Hours: 20:00
Castle Biosciences SG&A Expense (Quarterly): 50.50M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Delcath Systems Inc | 6.953M |
| CytoSorbents Corp | 7.827M |
| CytomX Therapeutics Inc | 7.953M |
| Spero Therapeutics Inc | 5.198M |
| Progyny Inc | 46.79M |